Hemostasis Diagnostics Market Size, Share, Growth Report 2032

Hemostasis Diagnostics Market Size

The global hemostasis diagnostics market size was worth around USD 581.84 million in 2023 and is predicted to grow to around USD 1115.53 million by 2032 with a compound annual growth rate (CAGR) of roughly 7.5% between 2024 and 2032.

The study provides historical data from 2018 to 2022 along with a forecast from 2024 to 2032 based on revenue (USD Million). The report covers a forecast and an analysis of the Hemostasis Diagnostics market on a global and regional level.

Request Free Sample

Hemostasis Diagnostics Market: Overview

Hemostasis is a process of slowing down or stopping bleeding from damaged blood vessels during this process the blood changes from liquid to a gelatinous state. It is the first stage of wound healing. Hemostasis devices are used to detect hemostatic defects that can lead to excessive bleeding. The entire process of hemostasis has three steps: blood coagulation, vasoconstriction, and platelet plug formation. Hemostasis diagnostics also help in finding out the bleeding cause during surgical procedures by identifying the hemostatic defects.

The major factor that is likely to drive the hemostasis diagnostics market over the forecast timeframe is the increased prevalence of hemostasis disorders, such as hemophilia. As per the Centers for Disease Control and Prevention Report 2016, hemophilia A affects 1 in 5000 infants and around 400 babies are born with hemophilia annually. The increased occurrence of genetically inherited diseases is likely to fuel the hemostasis diagnostics market in the foreseeable future. Moreover, high investment in research and development is projected to drive the development of new and advanced products over the estimated years. Furthermore, technological advancements and increase acceptance of advanced technology are predicted to create new growth opportunities for the players operating in the hemostasis diagnostics market over the estimated timeline. However, the high cost of advanced hemostasis devices and stringent regulatory policies regarding the approval of these diagnostics might hamper the hemostasis diagnostics market in the future.

The study includes drivers and restraints of the Hemostasis Diagnostics Market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the Hemostasis Diagnostics Market on a global level.

In order to give the users of this report a comprehensive view of the Hemostasis Diagnostics Market, we have included a competitive landscape and an analysis of Porter’s Five Forces model of the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

Request Free Sample

The report provides company market share analysis to give a broader overview of the key market players. In addition, the report also covers key strategic developments in the market, including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved on the market on a global and regional basis.

Hemostasis Diagnostics Market: Segmentation

The study provides a decisive view of the hemostasis diagnostics market by segmenting the market based on product type, test type, end-user, and region. All the segments have been analyzed based on present and future trends and the market are estimated from 2024 to 2032. 

By product type, the hemostasis diagnostics market is segmented into laboratory systems, consumables, and point-of-care testing systems.

By test type, the hemostasis diagnostics market is segmented into prothrombin test time (PT), activated partial thromboplastin time (APTT), fibrinogen degradation products (FDP), activated clotting time, platelet aggregation test, and D dimer.

By end-user, the hemostasis diagnostics Market is segmented into hospital and clinics, independent diagnostic laboratories, and home care settings.

Hemostasis Diagnostics Market: Report Scope

Hemostasis Diagnostics Market: Regional Analysis

The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further segmentation into major countries, such as the U.S., Germany, France, UK, China, Japan, India, and Brazil. 

By region, the hemostasis diagnostics market includes North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America is expected to dominate the global hemostasis diagnostics market over the forecast timeline, owing to the presence of developed countries, such as the U.S. and Canada. The European market is expected to closely follow the North American market in terms of revenue. The Asia Pacific is likely to register the fastest rate of growth over the forecast time period.

Hemostasis Diagnostics Market: Competitive Players

The major players of the global hemostasis diagnostics market include:

• Siemens Healthineers
• Abbott Laboratories
• Instrumentation Laboratory
• Thermo Fisher Scientific Inc.
• Alere Inc.
• Nihon Kohden Corporation
• Sysmex Corporation
• Danaher Corporation
• F. Hoffmann-La Roche Ltd.
• Grifols S.A. 

This report segments the global hemostasis diagnostics market into:

Global Hemostasis Diagnostics Market: Product Type Analysis

• Laboratory Systems
• Consumables
• Point-of-Care Testing Systems

Global Hemostasis Diagnostics Market: Test Type Analysis

• Prothrombin Test Time (PT)
• Activated Partial Thromboplastin Time (APTT)
• Fibrinogen Degradation Products (FDP)
• Activated Clotting Time
• Platelet Aggregation Test
• D Dimer

Global Hemostasis Diagnostics Market: End-User Analysis

• Hospital and Clinics
• Independent Diagnostic Laboratories
• Home Care Settings

Global Hemostasis Diagnostics Market: Regional Analysis

• North America
  • The U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• Middle East and Africa